nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—SLC2A1—HIF-1-alpha transcription factor network—ID2—ocular cancer	0.0981	0.0981	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—ID2—ocular cancer	0.0849	0.0849	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—E2F3—ocular cancer	0.0661	0.0661	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—CDC25A—ocular cancer	0.0628	0.0628	CbGpPWpGaD
Etomidate—SLC2A1—Regulation of insulin secretion—GNA11—ocular cancer	0.0435	0.0435	CbGpPWpGaD
Etomidate—SLC2A1—Regulation of insulin secretion—GNAQ—ocular cancer	0.0404	0.0404	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—CCND2—ocular cancer	0.0357	0.0357	CbGpPWpGaD
Etomidate—SLC2A1—Integration of energy metabolism—GNA11—ocular cancer	0.0342	0.0342	CbGpPWpGaD
Etomidate—SLC2A1—Integration of energy metabolism—GNAQ—ocular cancer	0.0318	0.0318	CbGpPWpGaD
Etomidate—SLC2A1—HIF-2-alpha transcription factor network—EP300—ocular cancer	0.0279	0.0279	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—CDK4—ocular cancer	0.0239	0.0239	CbGpPWpGaD
Etomidate—CYP11B2—ACE Inhibitor Pathway—TGFB1—ocular cancer	0.0221	0.0221	CbGpPWpGaD
Etomidate—CYP19A1—Ovarian Infertility Genes—CCND2—ocular cancer	0.0188	0.0188	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—GNA11—ocular cancer	0.017	0.017	CbGpPWpGaD
Etomidate—SLC2A1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.0164	0.0164	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—GNAQ—ocular cancer	0.0158	0.0158	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—EP300—ocular cancer	0.0142	0.0142	CbGpPWpGaD
Etomidate—CYP19A1—Ovarian Infertility Genes—CDK4—ocular cancer	0.0126	0.0126	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PSPH—ocular cancer	0.0124	0.0124	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—MYC—ocular cancer	0.0124	0.0124	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—TP53—ocular cancer	0.0102	0.0102	CbGpPWpGaD
Etomidate—SLC2A1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.00992	0.00992	CbGpPWpGaD
Etomidate—SLC2A1—Disease—SAG—ocular cancer	0.00982	0.00982	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CDC25A—ocular cancer	0.00956	0.00956	CbGpPWpGaD
Etomidate—SLC2A1—Disease—E2F5—ocular cancer	0.00869	0.00869	CbGpPWpGaD
Etomidate—CYP19A1—Ovarian Infertility Genes—CDKN1B—ocular cancer	0.00852	0.00852	CbGpPWpGaD
Etomidate—SLC2A1—Disease—E2F4—ocular cancer	0.00851	0.00851	CbGpPWpGaD
Etomidate—SLC2A1—Disease—RPL39—ocular cancer	0.00835	0.00835	CbGpPWpGaD
Etomidate—SLC2A1—Disease—RBL1—ocular cancer	0.00835	0.00835	CbGpPWpGaD
Etomidate—SLC2A1—NRF2 pathway—TGFB1—ocular cancer	0.00756	0.00756	CbGpPWpGaD
Etomidate—CYP19A1—Tryptophan metabolism—MDM2—ocular cancer	0.00698	0.00698	CbGpPWpGaD
Etomidate—SLC2A1—Disease—TFDP1—ocular cancer	0.00673	0.00673	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PSPH—ocular cancer	0.00649	0.00649	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PSPH—ocular cancer	0.00559	0.00559	CbGpPWpGaD
Etomidate—SLC2A1—Insulin Signaling—HRAS—ocular cancer	0.00553	0.00553	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—HDAC1—ocular cancer	0.00543	0.00543	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MAML2—ocular cancer	0.00535	0.00535	CbGpPWpGaD
Etomidate—CYP19A1—FSH signaling pathway—AKT1—ocular cancer	0.00518	0.00518	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.00499	0.00499	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—TGFB1—ocular cancer	0.00493	0.00493	CbGpPWpGaD
Etomidate—SLC2A1—Insulin Signaling—AKT1—ocular cancer	0.00489	0.00489	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—E2F1—ocular cancer	0.00446	0.00446	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.00431	0.00431	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.00401	0.00401	CbGpPWpGaD
Etomidate—SLC2A1—Disease—HDAC1—ocular cancer	0.00391	0.00391	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GNA11—ocular cancer	0.00391	0.00391	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CDK2—ocular cancer	0.00385	0.00385	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CDK4—ocular cancer	0.00364	0.00364	CbGpPWpGaD
Etomidate—ADRA2B—Platelet Aggregation (Plug Formation)—AKT1—ocular cancer	0.00364	0.00364	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GNAQ—ocular cancer	0.00363	0.00363	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CDKN2B—ocular cancer	0.0035	0.0035	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—AKT1—ocular cancer	0.00343	0.00343	CbGpPWpGaD
Etomidate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—ocular cancer	0.00339	0.00339	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PSPH—ocular cancer	0.00317	0.00317	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—RB1—ocular cancer	0.00316	0.00316	CbGpPWpGaD
Etomidate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—ocular cancer	0.0031	0.0031	CbGpPWpGaD
Etomidate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—ocular cancer	0.00271	0.00271	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.0027	0.0027	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—MDM2—ocular cancer	0.00255	0.00255	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.00235	0.00235	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—MDM2—ocular cancer	0.00233	0.00233	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—GNA11—ocular cancer	0.00222	0.00222	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.00216	0.00216	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—GNAQ—ocular cancer	0.00207	0.00207	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GNA11—ocular cancer	0.00204	0.00204	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—MDM2—ocular cancer	0.00203	0.00203	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—EP300—ocular cancer	0.00199	0.00199	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—MDM2—ocular cancer	0.00195	0.00195	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MDM2—ocular cancer	0.00194	0.00194	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GNAQ—ocular cancer	0.0019	0.0019	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.00189	0.00189	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—HDAC1—ocular cancer	0.00186	0.00186	CbGpPWpGaD
Etomidate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.00186	0.00186	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—MDM2—ocular cancer	0.00178	0.00178	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CDKN1B—ocular cancer	0.00177	0.00177	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GNA11—ocular cancer	0.00176	0.00176	CbGpPWpGaD
Etomidate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.0017	0.0017	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CDKN1A—ocular cancer	0.00164	0.00164	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GNAQ—ocular cancer	0.00164	0.00164	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SAG—ocular cancer	0.00159	0.00159	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—MDM2—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Etomidate—SLC2A1—Disease—EP300—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.00155	0.00155	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.00153	0.00153	CbGpPWpGaD
Etomidate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.00149	0.00149	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GNA11—ocular cancer	0.0014	0.0014	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—E2F5—ocular cancer	0.0014	0.0014	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—HRAS—ocular cancer	0.0014	0.0014	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—E2F4—ocular cancer	0.00137	0.00137	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MYC—ocular cancer	0.00136	0.00136	CbGpPWpGaD
Etomidate—SLC2A1—Disease—TGFB1—ocular cancer	0.00135	0.00135	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RBL1—ocular cancer	0.00135	0.00135	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—CDK2—ocular cancer	0.00132	0.00132	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.00132	0.00132	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.00131	0.00131	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GNAQ—ocular cancer	0.00131	0.00131	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—EP300—ocular cancer	0.00131	0.00131	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—HRAS—ocular cancer	0.00128	0.00128	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GNA11—ocular cancer	0.00128	0.00128	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.00125	0.00125	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GNAQ—ocular cancer	0.00119	0.00119	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—E2F3—ocular cancer	0.00117	0.00117	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—HRAS—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TFDP1—ocular cancer	0.00109	0.00109	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—HRAS—ocular cancer	0.00107	0.00107	CbGpPWpGaD
Etomidate—SLC2A1—Disease—HRAS—ocular cancer	0.00107	0.00107	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GNA11—ocular cancer	0.000998	0.000998	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—HRAS—ocular cancer	0.000979	0.000979	CbGpPWpGaD
Etomidate—SLC2A1—Disease—AKT1—ocular cancer	0.000942	0.000942	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GNAQ—ocular cancer	0.000928	0.000928	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.00087	0.00087	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MAML2—ocular cancer	0.000863	0.000863	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—HRAS—ocular cancer	0.000856	0.000856	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—AKT1—ocular cancer	0.000789	0.000789	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GNA11—ocular cancer	0.000753	0.000753	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000749	0.000749	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—EP300—ocular cancer	0.000742	0.000742	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GNAQ—ocular cancer	0.0007	0.0007	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—EP300—ocular cancer	0.000683	0.000683	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TGFB1—ocular cancer	0.000645	0.000645	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HDAC1—ocular cancer	0.000631	0.000631	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—EP300—ocular cancer	0.000588	0.000588	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CDKN2B—ocular cancer	0.000566	0.000566	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TP53—ocular cancer	0.000531	0.000531	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—E2F1—ocular cancer	0.000519	0.000519	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—HRAS—ocular cancer	0.000508	0.000508	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—AKT1—ocular cancer	0.000449	0.000449	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—AKT1—ocular cancer	0.000412	0.000412	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—AKT1—ocular cancer	0.000355	0.000355	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—EP300—ocular cancer	0.000333	0.000333	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MDM2—ocular cancer	0.000314	0.000314	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HRAS—ocular cancer	0.000292	0.000292	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CDKN1B—ocular cancer	0.000287	0.000287	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AKT1—ocular cancer	0.000283	0.000283	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCND1—ocular cancer	0.000273	0.000273	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CDKN1A—ocular cancer	0.000264	0.000264	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AKT1—ocular cancer	0.000257	0.000257	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EP300—ocular cancer	0.000252	0.000252	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MYC—ocular cancer	0.000219	0.000219	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TGFB1—ocular cancer	0.000219	0.000219	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—AKT1—ocular cancer	0.000201	0.000201	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TP53—ocular cancer	0.00018	0.00018	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HRAS—ocular cancer	0.000172	0.000172	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AKT1—ocular cancer	0.000152	0.000152	CbGpPWpGaD
